Aton Ra Partners Dexcom Inc Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Dexcom Inc stock. As of the latest transaction made, Aton Ra Partners holds 8,296 shares of DXCM stock, worth $665,671. This represents 2.05% of its overall portfolio holdings.

Number of Shares

8,296

Previous 8,943 7.23%

Holding current value

$665,671

Previous $834,000 23.38%

% of portfolio

2.05%

Previous 1.75%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$75.49 - $124.16 $48,842 - $80,331	-647 Reduced 7.23%	8,296 $1.03 Million
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $18,244 - $29,241	-212 Reduced 2.32%	8,943 $834,000
Q2 2023 Jul 18, 2023	SELL	$112.47 - $130.98 $380,935 - $443,629	-3,387 Reduced 27.01%	9,155 $1.18 Million
Q1 2023 May 05, 2023	SELL	$104.0 - $122.92 $183,456 - $216,830	-1,764 Reduced 12.33%	12,542 $1.46 Million
Q4 2022 Feb 02, 2023	SELL	$84.98 - $122.67 $94,752 - $136,777	-1,115 Reduced 7.23%	14,306 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $68,485 - $84,479	897 Added 6.18%	15,421 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $632,374 - $1.24 Million	9,301 Added 178.08%	14,524 $1.08 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $192,487 - $266,389	-2,046 Reduced 28.15%	5,223 $2.67 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $121,428 - $152,236	-935 Reduced 11.4%	7,269 $3.9 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $83,020 - $111,394	778 Added 10.48%	8,204 $4.49 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $221,750 - $295,512	2,738 Added 58.4%	7,426 $3.17 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $168,816 - $208,537	1,991 Added 73.82%	4,688 $1.69 Million
Q4 2020 Feb 19, 2021	BUY	$78.0 - $104.5 $210,366 - $281,836	2,697 New	2,697 $997,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account